Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03962491 · ClinicalTrials.gov registry record · NA
Mobile-Based Contingency Management to Promote Daily Self-monitoring in Primary Care Patients
A NA study of Pain, Chronic, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
- 1
- Study location
NCT03962491: Completed NA study of Pain, Chronic, sponsored by Virginia Commonwealth University.
NCT03962491 is a NA study of Pain, Chronic that has completed, run by Virginia Commonwealth University. The registered enrollment target is 81 participants, below the 720-participant average among 48 other Pain, Chronic trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03962491, a NA study of Pain, Chronic, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
- 1
- Study location
Study Summary
This project examines the efficacy and feasibility of contingency management (CM), delivered using a novel, fully automated CM app (DynamiCare Rewards), to promote daily self-monitoring of pain symptom severity and related variables (e.g., mood, sleep), as well as Rx opioid, alcohol, marijuana, cannabidiol (CBD), and Rx benzodiazepine use in a sample of chronic pain patients. The project will conduct a 2-arm randomized clinical trial (RCT) comparing those receiving reinforcement escalating with continuous performance of the target behavior (CM group) vs those asked to complete the survey but will not be incentivized (C group).
Primary Outcome
Number of days daily surveys completed
Conditions Studied
Interventions
- BEHAVIORAL Daily Self-Monitoring Surveys + Contingency Management
- BEHAVIORAL Daily Self-Monitoring Surveys
Study Locations (1)
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2020-01-24 |
| Est. Completion | 2021-04-14 |
| Phase | NA |
What the finished NCT03962491 record still lists
NCT03962491 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 81 participants, a relatively small participant target, below the 720-participant average among 48 other Pain, Chronic trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Pain, Chronic appearing as the primary indexed condition, and to 2 interventions - of which Daily Self-Monitoring Surveys + Contingency Management is the first listed.
NCT03962491 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT03962491 about?
NCT03962491 is a clinical study titled "Mobile-Based Contingency Management to Promote Daily Self-monitoring in Primary Care Patients". This project examines the efficacy and feasibility of contingency management (CM), delivered using a novel, fully automated CM app (DynamiCare Rewards), to promote daily self-monitoring of pain symptom severity and related variables (e.g., mood, sleep), as well as Rx opioid, alcohol, marijuana, cann...
What is the current status of trial NCT03962491?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2020-01-24. Estimated completion is 2021-04-14.
What conditions does trial NCT03962491 study?
This clinical trial studies the following conditions: Pain, Chronic.
What interventions are being tested in trial NCT03962491?
The interventions under investigation include: Daily Self-Monitoring Surveys + Contingency Management (BEHAVIORAL), Daily Self-Monitoring Surveys (BEHAVIORAL).
Who is sponsoring clinical trial NCT03962491?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03962491 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Chronic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03962491's enrollment target sits among peer trials
81 27th of 48 higher than 22 of 48 other Pain, Chronic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Chronic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
RECRUITING · NA
-
Pain and Weight Treatment: Development and Trial of PAW
RECRUITING · NA
-
VR and Cooled Genicular Nerve Radio Frequency Ablation for Chronic Knee Pain
RECRUITING · NA
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
-
Pain and Opioid Management in Older Adults
RECRUITING · NA
-
Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI